No Data
Zimmer Biomet Holdings Is Maintained at In-Line by Evercore ISI Group
Zimmer Biomet Holdings Is Maintained at In-Line by Evercore ISI Group
Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $115
Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings with a In-Line and lowers the price target from $130 to $115.
Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $115
Evercore analyst Vijay Kumar maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and adjusts the target price from $125 to $115.According to TipRanks data, the analyst has a success rate of
Evercore ISI Adjusts Price Target on Zimmer Biomet Holdings to $115 From $130, Maintains In-Line Rating
Zimmer Biomet Holdings (ZBH) has an average hold rating and a price target range of $112 to $175, according to analysts polled by Capital IQ. Price: 106.20, Change: +0.24, Percent Change: +0.23
Express News | Zimmer Biomet Holdings Inc: 364-Day Revolving Credit Agreement Is an Unsecured Revolving Credit Facility in Principal Amount of $1 Bln
Express News | Zimmer Biomet Holdings: Five-Year Credit Agreement Includes Uncommitted Incremental Feature for Co to Request Increase of Facility by up to $500 Mln